The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Regulatory News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block Listing Six Monthly Return

14 Sep 2020 16:30

RNS Number : 9441Y
4d Pharma PLC
14 September 2020
 

14 September 2020

 

4D pharma plc

 

(the "Company" or "4D")

 

Block Listing Six Monthly Return

 

Name of applicant:

4D Pharma plc

Name of scheme:

Block Admission for February 2020 warrants

Period of return:

From:

10 March 2020

To:

9 September 2020

Number of securities originally admitted at date of admission:

22,000,000 Ordinary Shares of 0.25p each on 10 March 2020

Balance of unallotted securities under scheme(s) from previous return:

22,000,000 Ordinary shares

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0 Ordinary shares

Less: Number of securities issued/allotted under scheme(s) during period:

0 Ordinary shares

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

22,000,000 Ordinary shares

 

Name of contact:

Duncan Peyton

Telephone number of contact:

Company Secretary (0113 895 0130)

 

 

Contact Information:

4D

Duncan Peyton, Chief Executive Officer +44 (0)113 895 0130

Investor Relations ir@4dpharmaplc.com

 

N+1 Singer - Nominated Adviser and Joint Broker +44 (0)20 7496 3000

Aubrey Powell / Justin McKeegan / Iqra Amin (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

Bryan Garnier & Co. Limited - Joint Broker +44 (0)20 7332 2500

Dominic Wilson / Phil Walker

 

Image Box Communications

Neil Hunter / Michelle Boxall +44 (0)20 8943 4685

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRBUGDCIBBDGGS
Date   Source Headline
19th Jul 20167:00 amRNSClinical Update
10th Jun 20167:00 amRNSClinical Update
23rd May 20164:40 pmRNSSecond Price Monitoring Extn
23rd May 20164:35 pmRNSPrice Monitoring Extension
23rd May 20162:35 pmRNSResult of AGM
23rd May 20167:00 amRNSClinical Update
22nd Apr 201610:49 amRNSAnnual Report and Notice of AGM
8th Apr 20167:00 amRNSAcquisition
31st Mar 20167:00 amRNSFinal Results
29th Feb 20164:40 pmRNSSecond Price Monitoring Extn
29th Feb 20164:35 pmRNSPrice Monitoring Extension
26th Feb 20167:00 amRNSClinical Update
11th Feb 20164:40 pmRNSSecond Price Monitoring Extn
11th Feb 20164:35 pmRNSPrice Monitoring Extension
10th Feb 20167:00 amRNSAcquisition
22nd Jan 20167:00 amRNSChange of Registered Office
19th Jan 20167:00 amRNSClinical Update
4th Jan 20169:04 amRNSHolding(s) in Company
21st Dec 20153:44 pmRNSHolding(s) in Company
17th Dec 201510:21 amRNSHolding(s) in Company
17th Dec 201510:17 amRNSHolding(s) in Company
11th Dec 20152:37 pmRNSHolding(s) in Company
11th Dec 20152:37 pmRNSHolding(s) in Company
11th Dec 20152:33 pmRNSHolding(s) in Company
8th Dec 20157:00 amRNSPlacing
3rd Dec 201512:38 pmRNSHolding(s) in Company
26th Nov 20157:00 amRNSResearch Update on MicroRx Discovery Platform
11th Nov 20157:00 amRNSClinical Trial Update
13th Oct 20157:00 amRNSHolding(s) in Company
30th Sep 20159:09 amRNSHolding(s) in Company
29th Sep 20157:00 amRNSInterim results for the period ended 30 June 2015
21st Aug 20157:00 amRNSClinical Trial Update
7th Aug 20157:00 amRNSResearch Collaboration
29th Jun 201510:56 amRNSResult of AGM
23rd Jun 20157:00 amRNSHolding(s) in Company
16th Jun 20157:00 amRNSResearch Update
5th Jun 20157:00 amRNSFinal Results
20th May 20157:00 amRNSResearch Update
22nd Apr 20152:48 pmRNSHolding(s) in Company
1st Apr 201510:53 amRNSHolding(s) in Company
30th Mar 20153:47 pmRNSAcquisition of minority interests
11th Feb 20153:38 pmRNSHolding(s) in Company
11th Feb 20152:28 pmRNSHolding(s) in Company
10th Feb 20154:04 pmRNSHolding(s) in Company
9th Feb 201510:17 amRNSResult of general meeting
21st Jan 20157:00 amRNSPlacing
7th Jan 20157:00 amRNSResearch Update
5th Jan 20157:00 amRNSResearch Update
6th Nov 20149:19 amRNSHolding(s) in Company
3rd Oct 201410:53 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.